Pindolol's intrinsic sympathomimetic activity offers potential therapeutic advantages, including maintenance of normal cardiac output and reduced risk of bronchoconstriction and rebound phenomena.
No takes yet. Share an insight, caveat, or question.
Pindolol may be considered when cardiac output preservation or bronchospasm avoidance is prioritized; leaves open randomized comparisons versus modern beta-blockers.
WH Aellig (1982) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: